- Tripterifordin
-
- $103.00
-
2026-05-06
- CAS:139122-81-9
- Purity: 99.52%
- Supply Ability: 10g
- tripterifordin
-
- $3.00
-
2020-01-18
- CAS:139122-81-9
- Min. Order: 1KG
- Purity: 98%
- Supply Ability: 1kg , 5kg, 50kg
|
| | tripterifordin Basic information |
| Product Name: | tripterifordin | | Synonyms: | tripterifordin;TRIPTERIFORDIN; HYPODIOLIDE A;Antriptolactone;Hydroxyodolide;Kauran-18-oic acid, 16,20-dihydroxy-, δ-lactone, (4α)-;ripterifordin;(4S,4aS,6aS,8R,9R,11aS,11bR)-8-hydroxy-4,8-dimethyldodecahydro-1H-6a,9-methano-4,11b-(methanooxymethano)cyclohepta[a]naphthalen-14-one;inhibit,HIV,Human immunodeficiency virus,replication,Tripterifordin,anti-HIV,Inhibitor | | CAS: | 139122-81-9 | | MF: | C20H30O3 | | MW: | 318.45 | | EINECS: | | | Product Categories: | Diterpenoids | | Mol File: | 139122-81-9.mol |  |
| | tripterifordin Chemical Properties |
| Boiling point | 485.1±45.0 °C(Predicted) | | density | 1.19±0.1 g/cm3(Predicted) | | storage temp. | Store at -20°C | | solubility | Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc. | | form | Powder | | pka | 15.24±0.40(Predicted) | | InChI | InChI=1/C20H30O3/c1-17-7-3-8-20(12-23-16(17)21)14(17)6-9-19-10-13(4-5-15(19)20)18(2,22)11-19/h13-15,22H,3-12H2,1-2H3/t13-,14-,15+,17+,18-,19+,20+/s3 | | InChIKey | KLMZPLYXGZZBCX-VDOIHNSCNA-N | | SMILES | [C@H]12CC[C@H]3[C@@](O)(C)C[C@]1(CC[C@@H]1[C@]4(C)CCC[C@@]21COC4=O)C3 |&1:0,3,4,8,11,12,17,r| |
| | tripterifordin Usage And Synthesis |
| Uses | Tripterifordin possesses significant anti-HIV replication activities in H9 lymphocyte cells with an EC50value of 3100 nM, respectively[1]. | | Definition | ChEBI: A kaurane diterpenoid that is (5beta,8alpha,13alpha)-18,20-epoxykauran-18-one substituted by a hydroxy group at position 16. Isolated from the roots of Tripterygium wilfordii, it exhibits anti
HIV activity. | | target | HIV | Immunology & Inflammation related | | References | [1] Kobayashi S,et al. Synthesesof (-)-Tripterifordinand (-)-NeotripterifordinfromStevioside.J Org Chem.2018 Feb 2;83(3):1606-1613. DOI:10.1021/acs.joc.7b02916 |
| | tripterifordin Preparation Products And Raw materials |
|